Aid International, BioMed Central’s partner charity, invites
you to take part in their epic cycle challenge across Vietnam to Cambodia.
Taking place from 29th October to 7th November, participants
will raise sponsorship money to help Computer
Aid International reach more disadvantaged children and communities to enable
them to access the benefits of IT. Following
the hugely successful London to Paris Bike
Ride earlier this month, this event will
similarly cater for all levels of ability and promises to be an unforgettable
Starting in Vietnam’s Ho Chi Minh City
(Saigon) and finishing at Angkor Wat in Cambodia 10 days later, you’ll
experience breathtaking scenery, timeless traditions, ancient temples and the
warmth of the local people. Please …
Case reports can provide detailed information about a medical condition and can act as the first line of evidence for an adverse effect to medicine or a new emerging disease; however, they are often disregarded in the medical literature. To address this issue, Journal of Medical Case Reports has sought to provide a dedicated home to high quality case reports that expand medical knowledge. This week the journal launches its first thematic series on the importance of case reporting across all fields of medicine, edited by Editor-in-Chief Professor Michael Kidd.
This collection features articles highlighting the benefits of case reporting in neurology, skull base surgery, oncology, oral medicine and infectious disease. In …
In the latest round of evaluation a further five BioMed Central journals have been accepted for Impact Factor tracking by Thomson Reuters (ISI).
BMC International Health and Human Rights, Diabetology and Metabolic Syndrome, Italian Journal of Pediatrics, Journal of Ethnobiology and Ethnomedicine and Journal of Ovarian Research are all due to receive their first Impact Factors in 2012.
Full details on indexing of all BioMed Central journals is available on our website.
Guest blog post by Alex Wade, Director for Scholarly Communication at Microsoft Research, sponsors of BioMed Central’s Open Data Award.This has also been posted to the Microsoft Research Connections Blog.
Earlier this year, Lee Dirks, Cheri Ekholm, and I attended Phil Bourne’s Beyond the PDF workshop at the University of California, San Diego. This workshop advanced the premise that scholarly communication can and should evolve from static and disparate data and knowledge representation, as embodied in today’s typical PDF representations of research papers, to a rich integrated content which grows and changes the more we learn. In the few months since this event, there’s been a great deal of activity: Martin Fenner and Mark Hahnel are …
BMC Medicine is seeking submissions of original research offering novel translational and clinical insights into stem cell therapies, to be presented as part of an ongoing stem cell series. With this thematic series, which will have its own dedicated webpage, we aim to highlight some of the most important and topical issues – including recent advances, controversies and challenges in stem cell research, and of course their clinical implications.
To kick-start the series, three specially commissioned articles for BMC Medicine highlight some of the most important and topical issues in clinical stem cell research. In a ‘call to arms’ for translational researchers, Hans Snoeck describes the as yet unrealized potential of differentiating human pluripotent stem cells into thymic …
Stem Cell Research & Therapy, the home of translational research into stem cell therapeutics, recently celebrated its first anniversary. In an editorial marking the occasion, Editors-in-Chief Rocky Tuan and Timothy O’Brien look back at some of the highlights of the journal’s first year of publication.
Launched in March 2010, Stem Cell Research & Therapy publishes peer-reviewed open access research alongside high-quality commissioned content available by subscription. With stem cell research and its funding rarely out of the news, Stem Cell Research & Therapy provides an important forum for the dissemination and discussion of the results of such research. The journal published 50 articles in its first year of publication, and these have been well-accessed …
“The notion of systematic review – looking at the totality of evidence – is quietly one of the most important innovations in medicine over the past 30 years.”
– Dr Ben Goldacre, award-winning Bad Science columnist and medical doctor, in Testing Treatments
Systematic reviews and meta-analyses are widely considered as the highest level of evidence on which to inform medical practice decisions. There has been a sharp increase in the number of systematic reviews published in recent years, with well over 5,000 systematic reviews recorded in the MEDLINE database in 2009 alone. Prospective study registration, as is required for clinical trials, is also becoming established for systematic reviews. With increasing amounts of – and attention on – this …
Vaccinations, generally considered to be the most effective method for preventing infectious diseases, provide protection in terms of human cost, and may also provide good economic value. Cost effectiveness is an important factor for stakeholders in deciding whether to add an additional vaccine into the national vaccination program. Mathematical cost effectiveness models are useful in aiding decisions on whether or not to implement a new vaccination program.
Raymond Hutubessy and colleagues from the World Health Organization (WHO) have today published a series of three articles for BMC Medicine that aim to make decision makers more aware of the intricacies of different types of cost effectiveness models, and to encourage modelers to share their expertise. In a debate …
Despite being the seventh leading cause of death in the United States and costing the country over $100 billion a year, there remain no proven disease-modifying therapies for Alzheimer’s disease (AD). Progress in translating our understanding of the disease into effective therapies is limited when compared, for example, with HIV/AIDS, the causative agents of which were discovered during a similar period in history to those of AD, and for which multiple anti-viral therapies developed over two decades have transformed a fatal disease into one that is more manageable, at least in industrialized nations.
An editorial published last week in Alzheimer’s Research & Therapy by two of its Editors-in-Chief, Todd Golde and Douglas Galasko, and their co-author Bruce Lamb, …
Central has announced a new agreement with Edanz, a leading medical and
scientific editing service provider, to provide researchers with cost-effective
and comprehensive English language support throughout the peer review process.
As part of this agreement, BioMed Central authors will be eligible to receive a
discount on Edanz’s services.
agreement will significantly improve the publishing experience of BioMed
Central authors worldwide, allowing them to obtain English language assistance
wherever they need it.
services are provided by expert scientists and will support authors through
manuscript submission, peer-review,addressing reviewers’ comments, as well as
assistance with writing cover letters and advising on the most appropriate
journal for their papers. In addition, Edanz will be providing free workshops